Extendicare（EXE）株式概要Extendicare Inc.はその子会社を通じて、カナダで高齢者向けのケアとサービスを提供している。 詳細EXE ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長1/6過去の実績6/6財務の健全性6/6配当金4/6報酬当社が推定した公正価値より4.5%で取引されている 収益は年間14.13%増加すると予測されています 過去1年間で収益は58.6%増加しました リスク分析過去3か月間に大規模なインサイダー売却が発生 すべてのリスクチェックを見るEXE Community Fair Values Create NarrativeSee what 15 others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCA$Current PriceCA$34.051.4% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture03b2016201920222025202620282031Revenue CA$3.4bEarnings CA$236.9mAdvancedSet Fair ValueView all narrativesExtendicare Inc. 競合他社Sienna Senior LivingSymbol: TSX:SIAMarket cap: CA$2.3bMedical FacilitiesSymbol: TSX:DRMarket cap: CA$312.7mWELL Health TechnologiesSymbol: TSX:WELLMarket cap: CA$1.1bHuaxia Eye Hospital GroupLtdSymbol: SZSE:301267Market cap: CN¥13.6b価格と性能株価の高値、安値、推移の概要Extendicare過去の株価現在の株価CA$34.0552週高値CA$35.8652週安値CA$12.12ベータ1.161ヶ月の変化0.38%3ヶ月変化34.06%1年変化141.83%3年間の変化394.91%5年間の変化295.93%IPOからの変化2,494.29%最新ニュースRecent Insider Transactions • 21hNon Executive Chairman of the Board recently sold CA$5.0m worth of stockOn the 19th of June, Samir Manji sold around 147k shares on-market at roughly CA$33.88 per share. This transaction amounted to 82% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Samir has been a net seller over the last 12 months, reducing personal holdings by CA$5.3m.Declared Dividend • Jun 19Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jun 15Extendicare Inc. Declares Cash Dividend for the Month of June 2026, Payable on July 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026.Recent Insider Transactions • May 17Independent Director recently bought CA$347k worth of stockOn the 14th of May, Josh Blair bought around 10k shares on-market at roughly CA$34.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$479k more in shares than they have sold in the last 12 months.Price Target Changed • May 11Price target increased by 10% to CA$35.44Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year.Reported Earnings • May 11First quarter 2026 earnings released: EPS: CA$0.43 (vs CA$0.18 in 1Q 2025)First quarter 2026 results: EPS: CA$0.43 (up from CA$0.18 in 1Q 2025). Revenue: CA$465.2m (up 24% from 1Q 2025). Net income: CA$40.7m (up 171% from 1Q 2025). Profit margin: 8.8% (up from 4.0% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 66% per year.最新情報をもっと見るRecent updatesRecent Insider Transactions • 21hNon Executive Chairman of the Board recently sold CA$5.0m worth of stockOn the 19th of June, Samir Manji sold around 147k shares on-market at roughly CA$33.88 per share. This transaction amounted to 82% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Samir has been a net seller over the last 12 months, reducing personal holdings by CA$5.3m.Declared Dividend • Jun 19Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jun 15Extendicare Inc. Declares Cash Dividend for the Month of June 2026, Payable on July 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026.Recent Insider Transactions • May 17Independent Director recently bought CA$347k worth of stockOn the 14th of May, Josh Blair bought around 10k shares on-market at roughly CA$34.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$479k more in shares than they have sold in the last 12 months.Price Target Changed • May 11Price target increased by 10% to CA$35.44Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year.Reported Earnings • May 11First quarter 2026 earnings released: EPS: CA$0.43 (vs CA$0.18 in 1Q 2025)First quarter 2026 results: EPS: CA$0.43 (up from CA$0.18 in 1Q 2025). Revenue: CA$465.2m (up 24% from 1Q 2025). Net income: CA$40.7m (up 171% from 1Q 2025). Profit margin: 8.8% (up from 4.0% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 66% per year.ライブニュース • May 10Extendicare Expands Home Health Care With Major Acquisitions and Raises DividendExtendicare reported strong Q1 2026 results, with home health care cited as a key driver of performance. The company expanded its home health footprint through acquisitions of CBI Home Health, Closing the Gap and nine Class C long-term care homes. Extendicare issued $450 million of senior unsecured notes, restructured its credit facilities and announced a 5.0% increase in its monthly dividend. For you as an investor, the update highlights a clear push into home health services, supported by sizable acquisitions, including the $570 million purchase of CBI Home Health in April. The addition of Closing the Gap and nine Class C long-term care homes points to a larger and more diversified care platform, with a mix of in-home and facility-based services. On the balance sheet side, the $450 million senior unsecured notes and credit facility changes suggest the company is aligning its financing with this expanded scale. The 5.0% dividend increase, alongside a pre-tax gain realized from the sale of a vacated Class C property, reflects management’s current approach to capital returns while still funding growth. Investors may want to watch how integration of the new assets progresses, as well as how the updated capital structure affects interest costs and financial flexibility over time.お知らせ • May 09Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).Buy Or Sell Opportunity • Apr 24Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 33% to CA$29.61. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable.Declared Dividend • Apr 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th April 2026 Payment date: 15th May 2026 Dividend yield will be 1.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Apr 17+ 1 more updateExtendicare Inc. Announces April 2026 Cash Dividend, Payable on May 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of April 2026, which is payable on May 15, 2026 to shareholders of record at the close of business on April 30, 2026.Buy Or Sell Opportunity • Apr 09Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 35% to CA$29.52. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable.お知らせ • Apr 06Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026Recent Insider Transactions Derivative • Mar 20CEO, President & Director exercised options to buy CA$1.9m worth of stock.On the 17th of March, Michael Guerriere exercised options to buy 75k shares at a strike price of around CA$26.47, costing a total of CA$2.0m. This transaction amounted to 22% of their direct individual holding at the time of the trade. Since June 2025, Michael has owned 337.97k shares directly. Company insiders have collectively bought CA$6.9m more than they sold, via options and on-market transactions, in the last 12 months.Declared Dividend • Mar 19Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 31st March 2026 Payment date: 15th April 2026 Dividend yield will be 1.9%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Mar 19Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-ElectionExtendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate.Price Target Changed • Mar 01Price target increased by 15% to CA$29.08Up from CA$25.25, the current price target is an average from 5 analysts. New target price is 9.4% above last closing price of CA$26.58. Stock is up 114% over the past year. The company posted earnings per share of CA$1.13 last year.Reported Earnings • Feb 27Full year 2025 earnings released: EPS: CA$1.13 (vs CA$0.89 in FY 2024)Full year 2025 results: EPS: CA$1.13 (up from CA$0.89 in FY 2024). Revenue: CA$1.66b (up 13% from FY 2024). Net income: CA$96.7m (up 28% from FY 2024). Profit margin: 5.8% (up from 5.1% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 27Extendicare Inc. Increases Cash Dividend for the Month of March 2026Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases.Declared Dividend • Feb 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 27th February 2026 Payment date: 16th March 2026 Dividend yield will be 2.0%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Feb 17Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).分析記事 • Feb 14Extendicare (TSE:EXE) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...お知らせ • Jan 27Extendicare Inc., Annual General Meeting, Apr 16, 2026Extendicare Inc., Annual General Meeting, Apr 16, 2026.分析記事 • Jan 18Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 16th...Declared Dividend • Jan 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th January 2026 Payment date: 16th February 2026 Dividend yield will be 2.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jan 16Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026お知らせ • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).分析記事 • Jan 14Do Extendicare's (TSE:EXE) Earnings Warrant Your Attention?It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...分析記事 • Dec 27What Is Extendicare Inc.'s (TSE:EXE) Share Price Doing?While Extendicare Inc. ( TSE:EXE ) might not have the largest market cap around , it received a lot of attention from a...Declared Dividend • Dec 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st December 2025 Payment date: 15th January 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Dec 13Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).Recent Insider Transactions • Dec 07Senior VP of ParaMed & CTO recently bought CA$213k worth of stockOn the 4th of December, Steve Paraskevopoulos bought around 10k shares on-market at roughly CA$22.40 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$259k more in shares than they have sold in the last 12 months.Price Target Changed • Nov 26Price target increased by 16% to CA$22.25Up from CA$19.25, the current price target is an average from 3 analysts. New target price is 6.8% above last closing price of CA$20.83. Stock is up 98% over the past year. The company posted earnings per share of CA$0.89 last year.お知らせ • Nov 20Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million.Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million. For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million. The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share. CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health.分析記事 • Nov 19Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th...Declared Dividend • Nov 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 28th November 2025 Payment date: 15th December 2025 Dividend yield will be 2.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 25% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CA$19.76, the stock trades at a trailing P/E ratio of 18.2x. Average forward P/E is 43x in the Healthcare industry in Canada. Total returns to shareholders of 253% over the past three years.Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: CA$0.28 (vs CA$0.19 in 3Q 2024)Third quarter 2025 results: EPS: CA$0.28 (up from CA$0.19 in 3Q 2024). Revenue: CA$440.3m (up 23% from 3Q 2024). Net income: CA$24.1m (up 48% from 3Q 2024). Profit margin: 5.5% (up from 4.5% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.Price Target Changed • Nov 14Price target increased by 14% to CA$18.75Up from CA$16.51, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CA$19.18. Stock is up 92% over the past year. The company posted earnings per share of CA$0.89 last year.お知らせ • Nov 13Extendicare Inc. announces Monthly dividend, payable on December 15, 2025Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025.分析記事 • Nov 13Even With A 26% Surge, Cautious Investors Are Not Rewarding Extendicare Inc.'s (TSE:EXE) Performance CompletelyDespite an already strong run, Extendicare Inc. ( TSE:EXE ) shares have been powering on, with a gain of 26% in the...お知らせ • Oct 15Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Oct 07Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025Declared Dividend • Sep 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 29th September 2025 Payment date: 15th October 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Sep 15Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025.分析記事 • Aug 17Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.042Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th of September...Declared Dividend • Aug 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 29th August 2025 Payment date: 15th September 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.分析記事 • Aug 10When Should You Buy Extendicare Inc. (TSE:EXE)?TSX:EXE 1 Year Share Price vs Fair Value Explore Extendicare's Fair Values from the Community and select yours...Reported Earnings • Aug 08Second quarter 2025 earnings released: EPS: CA$0.38 (vs CA$0.31 in 2Q 2024)Second quarter 2025 results: EPS: CA$0.38 (up from CA$0.31 in 2Q 2024). Revenue: CA$383.4m (up 10.0% from 2Q 2024). Net income: CA$31.9m (up 23% from 2Q 2024). Profit margin: 8.3% (up from 7.4% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.お知らせ • Aug 07Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.分析記事 • Jul 19Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th...Declared Dividend • Jul 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st July 2025 Payment date: 15th August 2025 Dividend yield will be 3.8%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jul 15Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Jul 07Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025分析記事 • Jun 20Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.042Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th of July. This...Declared Dividend • Jun 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th June 2025 Payment date: 15th July 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jun 18Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Jun 03Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc.Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction. Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025.分析記事 • May 27Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.042Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.042 per share on 16th of June. This...Declared Dividend • May 16Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th May 2025 Payment date: 16th June 2025 Dividend yield will be 3.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Recent Insider Transactions • May 11Independent Director recently bought CA$199k worth of stockOn the 8th of May, Donald Clow bought around 14k shares on-market at roughly CA$14.19 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$143k more in shares than they have sold in the last 12 months.Reported Earnings • May 07First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: CA$374.7m (up 2.1% from 1Q 2024). Net income: CA$15.0m (up 15% from 1Q 2024). Profit margin: 4.0% (up from 3.6% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada.お知らせ • May 07Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025.分析記事 • Apr 28Extendicare's (TSE:EXE) Dividend Will Be CA$0.042Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.042 per share on 15th of May. Based on...Declared Dividend • Apr 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th April 2025 Payment date: 15th May 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Apr 16Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).お知らせ • Apr 03Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025Declared Dividend • Mar 20Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st March 2025 Payment date: 15th April 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Recent Insider Transactions Derivative • Mar 19CEO, President & Director exercised options to buy CA$1.0m worth of stock.On the 18th of March, Michael Guerriere exercised options to buy 79k shares at a strike price of around CA$13.03, costing a total of CA$1.0m. This transaction amounted to 31% of their direct individual holding at the time of the trade. Since March 2024, Michael has owned 258.82k shares directly. Company insiders have collectively bought CA$2.9m more than they sold, via options and on-market transactions, in the last 12 months.お知らせ • Mar 18Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Mar 17Extendicare Inc., Annual General Meeting, May 27, 2025Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canada分析記事 • Mar 06Market Might Still Lack Some Conviction On Extendicare Inc. (TSE:EXE) Even After 28% Share Price BoostExtendicare Inc. ( TSE:EXE ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...Reported Earnings • Feb 28Full year 2024 earnings released: EPS: CA$0.89 (vs CA$0.40 in FY 2023)Full year 2024 results: EPS: CA$0.89 (up from CA$0.40 in FY 2023). Revenue: CA$1.47b (up 12% from FY 2023). Net income: CA$75.2m (up 121% from FY 2023). Profit margin: 5.1% (up from 2.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 28+ 1 more updateExtendicare Inc. Announces Dividend IncreaseExtendicare Inc. announced improved performance and growth in all three business segments has resulted in the dividend payout ratio dropping below 50%. Accordingly, the Company will increase its dividend by 5.0% to 4.2 cents per month effective with the dividend to be declared in March 2025.分析記事 • Feb 21Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 17th of March. This means that the annual payment...Declared Dividend • Feb 20Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 28th February 2025 Payment date: 17th March 2025 Dividend yield will be 4.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Feb 14Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).Price Target Changed • Feb 05Price target increased by 8.6% to CA$11.40Up from CA$10.50, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CA$11.32. Stock is up 63% over the past year. The company posted earnings per share of CA$0.40 last year.Declared Dividend • Jan 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st January 2025 Payment date: 14th February 2025 Dividend yield will be 4.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025.お知らせ • Jan 13Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025Declared Dividend • Dec 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st December 2024 Payment date: 15th January 2025 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Dec 13Extendicare Announces December 2024 Dividend, Payable on January 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).分析記事 • Nov 19Shareholders Can Be Confident That Extendicare's (TSE:EXE) Earnings Are High QualityWhen companies post strong earnings, the stock generally performs well, just like Extendicare Inc.'s ( TSE:EXE ) stock...Declared Dividend • Nov 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 29th November 2024 Payment date: 16th December 2024 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Nov 14Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023)Third quarter 2024 results: EPS: CA$0.20 (up from CA$0.14 in 3Q 2023). Revenue: CA$359.1m (up 11% from 3Q 2023). Net income: CA$16.3m (up 38% from 3Q 2023). Profit margin: 4.5% (up from 3.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 13Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.Declared Dividend • Oct 18Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st October 2024 Payment date: 15th November 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Oct 15Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Oct 04Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024分析記事 • Sep 20Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 15th of October. This means that the annual payment...Declared Dividend • Sep 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Sep 16Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).分析記事 • Aug 16Extendicare's (TSE:EXE) Dividend Will Be CA$0.04Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.04 per share on 16th of September. This...Declared Dividend • Aug 15Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 30th August 2024 Payment date: 16th September 2024 Dividend yield will be 5.8%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (69% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Price Target Changed • Aug 14Price target increased by 10% to CA$9.17Up from CA$8.33, the current price target is an average from 3 analysts. New target price is 11% above last closing price of CA$8.23. Stock is up 20% over the past year. The company posted earnings per share of CA$0.40 last year.株主還元EXECA HealthcareCA 市場7D3.1%2.2%-0.9%1Y141.8%31.2%31.2%株主還元を見る業界別リターン: EXE過去 1 年間で31.2 % の収益を上げたCanadian Healthcare業界を上回りました。リターン対市場: EXE過去 1 年間で31.2 % の収益を上げたCanadian市場を上回りました。価格変動Is EXE's price volatile compared to industry and market?EXE volatilityEXE Average Weekly Movement5.1%Healthcare Industry Average Movement5.3%Market Average Movement9.9%10% most volatile stocks in CA Market17.1%10% least volatile stocks in CA Market3.8%安定した株価: EXE 、 Canadian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: EXEの 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1968n/aMichael Guerrierewww.extendicare.comエクステンディケア社は、その子会社を通じて、カナダで高齢者向けのケアとサービスを提供している。同社は、長期介護サービス、看護ケア、作業療法、理学療法、言語療法、日常生活支援などの在宅医療サービス、管理、コンサルティング、その他のサービスを第三者に提供している。Extendicare、ParaMed、Extendicare Assist、SGP Purchasing Partner Networkのブランドで事業を展開している。同社は1968年に法人化され、カナダのマーカムに本社を置いている。もっと見るExtendicare Inc. 基礎のまとめExtendicare の収益と売上を時価総額と比較するとどうか。EXE 基礎統計学時価総額CA$3.21b収益（TTM）CA$122.36m売上高(TTM)CA$1.75b26.4xPER（株価収益率1.8xP/SレシオEXE は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計EXE 損益計算書（TTM）収益CA$1.75b売上原価CA$1.50b売上総利益CA$255.63mその他の費用CA$133.28m収益CA$122.36m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）1.29グロス・マージン14.60%純利益率6.99%有利子負債／自己資本比率78.4%EXE の長期的なパフォーマンスは？過去の実績と比較を見る配当金1.5%現在の配当利回り36%配当性向EXE 配当は確実ですか？EXE 配当履歴とベンチマークを見るEXE 、いつまでに購入すれば配当金を受け取れますか？Extendicare 配当日配当落ち日Jun 30 2026配当支払日Jul 15 2026配当落ちまでの日数6 days配当支払日までの日数21 daysEXE 配当は確実ですか？EXE 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/22 18:48終値2026/06/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Extendicare Inc. 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Kyle McPheeATB CormarkTom CallaghanBMO Capital Markets Equity ResearchTania Armstrong-WhitworthCanaccord Genuity10 その他のアナリストを表示
Recent Insider Transactions • 21hNon Executive Chairman of the Board recently sold CA$5.0m worth of stockOn the 19th of June, Samir Manji sold around 147k shares on-market at roughly CA$33.88 per share. This transaction amounted to 82% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Samir has been a net seller over the last 12 months, reducing personal holdings by CA$5.3m.
Declared Dividend • Jun 19Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 15Extendicare Inc. Declares Cash Dividend for the Month of June 2026, Payable on July 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026.
Recent Insider Transactions • May 17Independent Director recently bought CA$347k worth of stockOn the 14th of May, Josh Blair bought around 10k shares on-market at roughly CA$34.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$479k more in shares than they have sold in the last 12 months.
Price Target Changed • May 11Price target increased by 10% to CA$35.44Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year.
Reported Earnings • May 11First quarter 2026 earnings released: EPS: CA$0.43 (vs CA$0.18 in 1Q 2025)First quarter 2026 results: EPS: CA$0.43 (up from CA$0.18 in 1Q 2025). Revenue: CA$465.2m (up 24% from 1Q 2025). Net income: CA$40.7m (up 171% from 1Q 2025). Profit margin: 8.8% (up from 4.0% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 66% per year.
Recent Insider Transactions • 21hNon Executive Chairman of the Board recently sold CA$5.0m worth of stockOn the 19th of June, Samir Manji sold around 147k shares on-market at roughly CA$33.88 per share. This transaction amounted to 82% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Samir has been a net seller over the last 12 months, reducing personal holdings by CA$5.3m.
Declared Dividend • Jun 19Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 15Extendicare Inc. Declares Cash Dividend for the Month of June 2026, Payable on July 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026.
Recent Insider Transactions • May 17Independent Director recently bought CA$347k worth of stockOn the 14th of May, Josh Blair bought around 10k shares on-market at roughly CA$34.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$479k more in shares than they have sold in the last 12 months.
Price Target Changed • May 11Price target increased by 10% to CA$35.44Up from CA$32.13, the current price target is an average from 9 analysts. New target price is 11% above last closing price of CA$31.81. Stock is up 122% over the past year. The company posted earnings per share of CA$1.13 last year.
Reported Earnings • May 11First quarter 2026 earnings released: EPS: CA$0.43 (vs CA$0.18 in 1Q 2025)First quarter 2026 results: EPS: CA$0.43 (up from CA$0.18 in 1Q 2025). Revenue: CA$465.2m (up 24% from 1Q 2025). Net income: CA$40.7m (up 171% from 1Q 2025). Profit margin: 8.8% (up from 4.0% in 1Q 2025). The increase in margin was driven by higher revenue. Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 64% per year whereas the company’s share price has increased by 66% per year.
ライブニュース • May 10Extendicare Expands Home Health Care With Major Acquisitions and Raises DividendExtendicare reported strong Q1 2026 results, with home health care cited as a key driver of performance. The company expanded its home health footprint through acquisitions of CBI Home Health, Closing the Gap and nine Class C long-term care homes. Extendicare issued $450 million of senior unsecured notes, restructured its credit facilities and announced a 5.0% increase in its monthly dividend. For you as an investor, the update highlights a clear push into home health services, supported by sizable acquisitions, including the $570 million purchase of CBI Home Health in April. The addition of Closing the Gap and nine Class C long-term care homes points to a larger and more diversified care platform, with a mix of in-home and facility-based services. On the balance sheet side, the $450 million senior unsecured notes and credit facility changes suggest the company is aligning its financing with this expanded scale. The 5.0% dividend increase, alongside a pre-tax gain realized from the sale of a vacated Class C property, reflects management’s current approach to capital returns while still funding growth. Investors may want to watch how integration of the new assets progresses, as well as how the updated capital structure affects interest costs and financial flexibility over time.
お知らせ • May 09Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Buy Or Sell Opportunity • Apr 24Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 33% to CA$29.61. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable.
Declared Dividend • Apr 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th April 2026 Payment date: 15th May 2026 Dividend yield will be 1.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Apr 17+ 1 more updateExtendicare Inc. Announces April 2026 Cash Dividend, Payable on May 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of April 2026, which is payable on May 15, 2026 to shareholders of record at the close of business on April 30, 2026.
Buy Or Sell Opportunity • Apr 09Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 35% to CA$29.52. The fair value is estimated to be CA$24.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Meanwhile, the company has become profitable.
お知らせ • Apr 06Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026
Recent Insider Transactions Derivative • Mar 20CEO, President & Director exercised options to buy CA$1.9m worth of stock.On the 17th of March, Michael Guerriere exercised options to buy 75k shares at a strike price of around CA$26.47, costing a total of CA$2.0m. This transaction amounted to 22% of their direct individual holding at the time of the trade. Since June 2025, Michael has owned 337.97k shares directly. Company insiders have collectively bought CA$6.9m more than they sold, via options and on-market transactions, in the last 12 months.
Declared Dividend • Mar 19Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 31st March 2026 Payment date: 15th April 2026 Dividend yield will be 1.9%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (46% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 17% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Mar 19Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-ElectionExtendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate.
Price Target Changed • Mar 01Price target increased by 15% to CA$29.08Up from CA$25.25, the current price target is an average from 5 analysts. New target price is 9.4% above last closing price of CA$26.58. Stock is up 114% over the past year. The company posted earnings per share of CA$1.13 last year.
Reported Earnings • Feb 27Full year 2025 earnings released: EPS: CA$1.13 (vs CA$0.89 in FY 2024)Full year 2025 results: EPS: CA$1.13 (up from CA$0.89 in FY 2024). Revenue: CA$1.66b (up 13% from FY 2024). Net income: CA$96.7m (up 28% from FY 2024). Profit margin: 5.8% (up from 5.1% in FY 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 60% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 27Extendicare Inc. Increases Cash Dividend for the Month of March 2026Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases.
Declared Dividend • Feb 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 27th February 2026 Payment date: 16th March 2026 Dividend yield will be 2.0%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Feb 17Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
分析記事 • Feb 14Extendicare (TSE:EXE) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
お知らせ • Jan 27Extendicare Inc., Annual General Meeting, Apr 16, 2026Extendicare Inc., Annual General Meeting, Apr 16, 2026.
分析記事 • Jan 18Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 16th...
Declared Dividend • Jan 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th January 2026 Payment date: 16th February 2026 Dividend yield will be 2.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jan 16Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026
お知らせ • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
分析記事 • Jan 14Do Extendicare's (TSE:EXE) Earnings Warrant Your Attention?It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
分析記事 • Dec 27What Is Extendicare Inc.'s (TSE:EXE) Share Price Doing?While Extendicare Inc. ( TSE:EXE ) might not have the largest market cap around , it received a lot of attention from a...
Declared Dividend • Dec 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st December 2025 Payment date: 15th January 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (48% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 22% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Dec 13Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Recent Insider Transactions • Dec 07Senior VP of ParaMed & CTO recently bought CA$213k worth of stockOn the 4th of December, Steve Paraskevopoulos bought around 10k shares on-market at roughly CA$22.40 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$259k more in shares than they have sold in the last 12 months.
Price Target Changed • Nov 26Price target increased by 16% to CA$22.25Up from CA$19.25, the current price target is an average from 3 analysts. New target price is 6.8% above last closing price of CA$20.83. Stock is up 98% over the past year. The company posted earnings per share of CA$0.89 last year.
お知らせ • Nov 20Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million.Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million. For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million. The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share. CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health.
分析記事 • Nov 19Extendicare (TSE:EXE) Is Due To Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th...
Declared Dividend • Nov 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 28th November 2025 Payment date: 15th December 2025 Dividend yield will be 2.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 25% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improves as stock rises 22%After last week's 22% share price gain to CA$19.76, the stock trades at a trailing P/E ratio of 18.2x. Average forward P/E is 43x in the Healthcare industry in Canada. Total returns to shareholders of 253% over the past three years.
Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: CA$0.28 (vs CA$0.19 in 3Q 2024)Third quarter 2025 results: EPS: CA$0.28 (up from CA$0.19 in 3Q 2024). Revenue: CA$440.3m (up 23% from 3Q 2024). Net income: CA$24.1m (up 48% from 3Q 2024). Profit margin: 5.5% (up from 4.5% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 42% per year, which means it is significantly lagging earnings growth.
Price Target Changed • Nov 14Price target increased by 14% to CA$18.75Up from CA$16.51, the current price target is an average from 8 analysts. New target price is approximately in line with last closing price of CA$19.18. Stock is up 92% over the past year. The company posted earnings per share of CA$0.89 last year.
お知らせ • Nov 13Extendicare Inc. announces Monthly dividend, payable on December 15, 2025Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025.
分析記事 • Nov 13Even With A 26% Surge, Cautious Investors Are Not Rewarding Extendicare Inc.'s (TSE:EXE) Performance CompletelyDespite an already strong run, Extendicare Inc. ( TSE:EXE ) shares have been powering on, with a gain of 26% in the...
お知らせ • Oct 15Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Oct 07Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025
Declared Dividend • Sep 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 29th September 2025 Payment date: 15th October 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Sep 15Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025.
分析記事 • Aug 17Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.042Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th of September...
Declared Dividend • Aug 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 29th August 2025 Payment date: 15th September 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (49% earnings payout ratio) and cash flows (54% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 110% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
分析記事 • Aug 10When Should You Buy Extendicare Inc. (TSE:EXE)?TSX:EXE 1 Year Share Price vs Fair Value Explore Extendicare's Fair Values from the Community and select yours...
Reported Earnings • Aug 08Second quarter 2025 earnings released: EPS: CA$0.38 (vs CA$0.31 in 2Q 2024)Second quarter 2025 results: EPS: CA$0.38 (up from CA$0.31 in 2Q 2024). Revenue: CA$383.4m (up 10.0% from 2Q 2024). Net income: CA$31.9m (up 23% from 2Q 2024). Profit margin: 8.3% (up from 7.4% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
お知らせ • Aug 07Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.
分析記事 • Jul 19Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.042The board of Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th...
Declared Dividend • Jul 18Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st July 2025 Payment date: 15th August 2025 Dividend yield will be 3.8%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jul 15Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Jul 07Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025
分析記事 • Jun 20Extendicare (TSE:EXE) Will Pay A Dividend Of CA$0.042Extendicare Inc. ( TSE:EXE ) has announced that it will pay a dividend of CA$0.042 per share on the 15th of July. This...
Declared Dividend • Jun 19Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th June 2025 Payment date: 15th July 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 18Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Jun 03Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc.Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction. Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025.
分析記事 • May 27Extendicare (TSE:EXE) Has Affirmed Its Dividend Of CA$0.042Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.042 per share on 16th of June. This...
Declared Dividend • May 16Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th May 2025 Payment date: 16th June 2025 Dividend yield will be 3.3%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (53% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 41% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Recent Insider Transactions • May 11Independent Director recently bought CA$199k worth of stockOn the 8th of May, Donald Clow bought around 14k shares on-market at roughly CA$14.19 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought CA$143k more in shares than they have sold in the last 12 months.
Reported Earnings • May 07First quarter 2025 earnings releasedFirst quarter 2025 results: Revenue: CA$374.7m (up 2.1% from 1Q 2024). Net income: CA$15.0m (up 15% from 1Q 2024). Profit margin: 4.0% (up from 3.6% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.3% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare industry in Canada.
お知らせ • May 07Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025.
分析記事 • Apr 28Extendicare's (TSE:EXE) Dividend Will Be CA$0.042Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.042 per share on 15th of May. Based on...
Declared Dividend • Apr 17Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 30th April 2025 Payment date: 15th May 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Apr 16Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
お知らせ • Apr 03Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025
Declared Dividend • Mar 20Dividend of CA$0.042 announcedShareholders will receive a dividend of CA$0.042. Ex-date: 31st March 2025 Payment date: 15th April 2025 Dividend yield will be 3.7%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (54% earnings payout ratio) and cash flows (39% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 40% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Recent Insider Transactions Derivative • Mar 19CEO, President & Director exercised options to buy CA$1.0m worth of stock.On the 18th of March, Michael Guerriere exercised options to buy 79k shares at a strike price of around CA$13.03, costing a total of CA$1.0m. This transaction amounted to 31% of their direct individual holding at the time of the trade. Since March 2024, Michael has owned 258.82k shares directly. Company insiders have collectively bought CA$2.9m more than they sold, via options and on-market transactions, in the last 12 months.
お知らせ • Mar 18Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Mar 17Extendicare Inc., Annual General Meeting, May 27, 2025Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canada
分析記事 • Mar 06Market Might Still Lack Some Conviction On Extendicare Inc. (TSE:EXE) Even After 28% Share Price BoostExtendicare Inc. ( TSE:EXE ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...
Reported Earnings • Feb 28Full year 2024 earnings released: EPS: CA$0.89 (vs CA$0.40 in FY 2023)Full year 2024 results: EPS: CA$0.89 (up from CA$0.40 in FY 2023). Revenue: CA$1.47b (up 12% from FY 2023). Net income: CA$75.2m (up 121% from FY 2023). Profit margin: 5.1% (up from 2.6% in FY 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 28+ 1 more updateExtendicare Inc. Announces Dividend IncreaseExtendicare Inc. announced improved performance and growth in all three business segments has resulted in the dividend payout ratio dropping below 50%. Accordingly, the Company will increase its dividend by 5.0% to 4.2 cents per month effective with the dividend to be declared in March 2025.
分析記事 • Feb 21Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 17th of March. This means that the annual payment...
Declared Dividend • Feb 20Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 28th February 2025 Payment date: 17th March 2025 Dividend yield will be 4.2%, which is lower than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Feb 14Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Price Target Changed • Feb 05Price target increased by 8.6% to CA$11.40Up from CA$10.50, the current price target is an average from 5 analysts. New target price is approximately in line with last closing price of CA$11.32. Stock is up 63% over the past year. The company posted earnings per share of CA$0.40 last year.
Declared Dividend • Jan 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st January 2025 Payment date: 14th February 2025 Dividend yield will be 4.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025.
お知らせ • Jan 13Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025
Declared Dividend • Dec 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st December 2024 Payment date: 15th January 2025 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Dec 13Extendicare Announces December 2024 Dividend, Payable on January 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
分析記事 • Nov 19Shareholders Can Be Confident That Extendicare's (TSE:EXE) Earnings Are High QualityWhen companies post strong earnings, the stock generally performs well, just like Extendicare Inc.'s ( TSE:EXE ) stock...
Declared Dividend • Nov 17Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 29th November 2024 Payment date: 16th December 2024 Dividend yield will be 4.7%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by both earnings (63% earnings payout ratio) and cash flows (42% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 122% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Nov 14Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023)Third quarter 2024 results: EPS: CA$0.20 (up from CA$0.14 in 3Q 2023). Revenue: CA$359.1m (up 11% from 3Q 2023). Net income: CA$16.3m (up 38% from 3Q 2023). Profit margin: 4.5% (up from 3.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Healthcare industry in Canada. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 13Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.
Declared Dividend • Oct 18Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st October 2024 Payment date: 15th November 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Oct 15Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Oct 04Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024
分析記事 • Sep 20Extendicare (TSE:EXE) Has Announced A Dividend Of CA$0.04Extendicare Inc. ( TSE:EXE ) will pay a dividend of CA$0.04 on the 15th of October. This means that the annual payment...
Declared Dividend • Sep 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 5.2%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Sep 16Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
分析記事 • Aug 16Extendicare's (TSE:EXE) Dividend Will Be CA$0.04Extendicare Inc.'s ( TSE:EXE ) investors are due to receive a payment of CA$0.04 per share on 16th of September. This...
Declared Dividend • Aug 15Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 30th August 2024 Payment date: 16th September 2024 Dividend yield will be 5.8%, which is higher than the industry average of 4.5%. Sustainability & Growth Dividend is covered by earnings (69% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Price Target Changed • Aug 14Price target increased by 10% to CA$9.17Up from CA$8.33, the current price target is an average from 3 analysts. New target price is 11% above last closing price of CA$8.23. Stock is up 20% over the past year. The company posted earnings per share of CA$0.40 last year.
